Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug

By Pam Belluck from NYT Health
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic.
https://ift.tt/30M07J8
November 22, 2021 at 06:00AM